Search for Clinical Trial Results

Sponsored By

Radiodermatitis - 24 Studies Found

Status Study
Completed Study Name: Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis
Condition: Radiodermatitis
Date: 2014-09-20
Interventions:
  • Drug: Urea Dose A Urea cream f
Enrolling by invitation Study Name: Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis
Condition: Radiodermatitis
Date: 2014-09-25
Interventions:
  • Other: Chamomila recutita Gel

Enrolling by invitation Study Name: Management Radiodermatitis in Patients With Breast or Head and Neck Cancer
Condition: Radiodermatitis
Date: 2014-09-19
Interventions:
  • Other: Chamomilla recutita gel

Enrolling by invitation Study Name: Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients
Condition: Radiodermatitis
Date: 2014-11-05
Interventions:
  • Drug: 2000 mg of JBM-TC4 per day

Terminated Study Name: Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Condition: Radiodermatitis
Date: 2010-12-16
Interventions: Drug: Norepinephrine Approximately 1.6 or 4.6 mL of a 400 mM norepinephrine solution will be applied top
Terminated Study Name: Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Condition: Radiodermatitis
Date: 2015-08-19
Interventions:
  • Drug: Difinsa53 Difinsa53 crea
Completed Study Name: Oral Curcumin for Radiation Dermatitis
Condition: Radiation-induced Dermatitis
Date: 2010-11-22
Interventions:
  • Drug: Curcumin 4 Curcumin C3 C
Completed Study Name: Laser Therapy for the Management of Radiation Dermatitis
Condition: Radiation Dermatitis
Date: 2013-08-27
Interventions: Device: Low-Level Laser Therapy Low-Level Laser Therapy will be applied, twice a week, from the moment s
Withdrawn Study Name: Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
Condition: Radiodermatitis
Date: 2012-02-15
Interventions: Drug: Norepinephrine Approximately 4.65 mL of a norepinephrine solution (400 mM, 82.3 mg/mL) will be app
Withdrawn Study Name: Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis
Condition: Radiation Dermatitis
Date: 2014-01-30
Interventions:
  • Device: KAM1403 Gel
  • Device: aloevera gel
Next >>>